Fentonium bromide
Pharmaceutical drug
From Wikipedia, the free encyclopedia
Fentonium bromide (INN) is an anticholinergic and antispasmodic atropine derivative.[1] In the US its patent number is 3,356,682.[2] It is sold by Sanofi-Aventis and Zambon.[3]
| Clinical data | |
|---|---|
| ATC code | |
| Pharmacokinetic data | |
| Bioavailability | 1 |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ECHA InfoCard | 100.025.018 |
| Chemical and physical data | |
| Formula | C31H34BrNO4 |
| Molar mass | 564.520 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |